AKT1 and cancer: Inactivating mutation of PTEN and activating mutation of PIK3CA have been detected in many human cancers and have been known as major activating mechanisms of AKT-signalling pathway in cancers (Testa and Bellacosa, 2001; Samuels et al, 2004).